XML 21 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:      
Net income $ 4,693 $ 344,094 $ 34,383
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 13,794 13,338 13,279
Stock-based compensation expense 7,959 6,135 2,587
Inventory impairments and abandonments 15,282 3,109 8,307
Deferred and other income tax expense (benefit) 15,903 (326,360) (12,590)
Gain on sale of fixed assets (957) 0 0
Change in allowance for doubtful accounts (698) (193) (406)
Equity in (income) loss of unconsolidated entities and marketable securities (143) 1,294 (6,545)
Cash distributions of income from unconsolidated entities 165 224 566
Non-cash loss on extinguishment of debt 4,978 0 2,670
Changes in operating assets and liabilities:      
Increase in accounts receivable (149) (17,757) (11,681)
Decrease (increase) in income tax receivable 127 (373) 2,767
Decrease (increase) in inventory 129,028 (121,700) (230,138)
(Increase) decrease in other assets (471) (165) 1,292
(Decrease) increase in trade accounts payable (9,365) 7,302 22,437
(Decrease) increase in other liabilities (17,121) 10,260 13,002
Other changes 0 (257) (399)
Net cash provided by (used in) operating activities 163,025 (81,049) (160,469)
Cash flows from investing activities:      
Capital expenditures (12,219) (15,964) (14,553)
Proceeds from sale of fixed assets 2,624 0 0
Investments in unconsolidated entities (4,241) (4,944) (5,218)
Return of capital from unconsolidated entities and marketable securities 1,142 24,245 1,703
Increases in restricted cash (5,852) (5,546) (15,608)
Decreases in restricted cash 30,348 29,586 1,645
Net cash provided by (used in) investing activities 11,802 27,377 (32,031)
Cash flows from financing activities:      
Repayment of debt (828,221) (18,573) (307,602)
Proceeds from issuance of new debt 642,150 0 325,000
Repayment of borrowings from credit facility (90,000) (75,000) 0
Borrowings from credit facility 90,000 75,000 0
Debt issuance costs (11,246) (126) (5,490)
Other changes (222) (200) 287
Net cash (used in) provided by financing activities (197,539) (18,899) 12,195
Decrease in cash and cash equivalents (22,712) (72,571) (180,305)
Cash and cash equivalents at beginning of period 251,583 324,154 504,459
Cash and cash equivalents at end of period $ 228,871 $ 251,583 $ 324,154